Abstract
The platelet glycoprotein GPIIb/IIIa ( ␣ IIb  3 ) antagonist c7E3 Fab (the Fab fragment of the mouse/human chimeric monoclonal antibody 7E3; abciximab; ReoPro™) was approved for human use in the United States in December 1994 based on its safety and its efficacy in reducing the risk of ischemic complications after percutaneous coronary intervention (PCI; 1 angioplasty or atherectomy) (1, 2).The success of this agent reflects our emerging ability to identify adhesion molecules as therapeutic targets, and then construct effective inhibitors that meet the stringent safety standards required for a new drug.As the first rationally designed antiplatelet and anti-integrin receptor drug, c7E3 Fab serves as a prototype for other anti-integrin receptor, and more generally, antiadhesion receptor, agents designed to treat and/or prevent human disease.
Keywords
PlateletIntegrinPlatelet Glycoprotein GPIIb-IIIa ComplexPharmacologyReceptorMedicinePlatelet membrane glycoproteinChemistryPlatelet activationImmunologyInternal medicine
Affiliated Institutions
Related Publications
A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complex.
Considerable evidence indicates that the glycoprotein (GP) IIb/IIIa complex on human platelets functions as a receptor for fibrinogen, but little is known about the mechanism of...
Assignment of disulphide bonds in human platelet GPIIIa. A disulphide pattern for the <i>β</i>-subunits of the integrin family
Integrins are cell-surface heterodimers formed by the association of one alpha- and one beta-subunit. Glycoprotein IIIa (GPIIIa or beta 3 subunit) is the common beta-subunit of ...
Human platelets and megakaryocytes contain alternately spliced glycoprotein IIb mRNAs.
The earliest marker of the megakaryocyte lineage in human bone marrow is a heterodimeric complex of glycoproteins IIb (GPIIb) and IIIa (GPIIIa). GPIIb-IIIa is a member of the in...
Structure of human platelet membrane glycoproteins IIb and IIIa as determined by electron microscopy.
The glycoprotein (GP) IIb-IIIa complex was isolated from human platelet membranes and examined for glycoprotein stoichiometry and morphology. To determine the ratio of glycoprot...
A highly conserved sequence of the Arg-Gly-Asp-binding domain of the integrin beta 3 subunit is sensitive to stimulation
The Arg-Gly-Asp (RGD)-binding domain of GPIIb-IIIa has been localized in a fragment of the GPIIIa subunit that includes the sequence between amino acids 109 and 171. To examine,...
Publication Info
- Year
- 1997
- Type
- article
- Volume
- 99
- Issue
- 7
- Pages
- 1467-1471
- Citations
- 267
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
267
OpenAlex
Cite This
Barry S. Coller
(1997).
Platelet GPIIb/IIIa antagonists: the first anti-integrin receptor therapeutics..
Journal of Clinical Investigation
, 99
(7)
, 1467-1471.
https://doi.org/10.1172/jci119307
Identifiers
- DOI
- 10.1172/jci119307